OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 14

Showing 14 citing articles:

Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 5

Structural optimization and biological evaluation of indolin-2-one derivatives as novel CDK8 inhibitors for idiopathic pulmonary fibrosis
Jui‐Yi Hsu, Kai‐Cheng Hsu, Ching-Hsuan Chou, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117891-117891
Closed Access

Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access

Use quercetin for pulmonary fibrosis: a preclinical systematic review and meta-analysis
Xuanyu Wu, Xiang Xiao, Yuchen Su, et al.
Inflammopharmacology (2025)
Closed Access

Casual associations of thyroid function with inflammatory bowel disease and the mediating role of cytokines
Shuyun Wu, Jiazhi Yi, Bin Wu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3

Targeting mast cell activation alleviates anti-MHC I antibody and LPS-induced TRALI in mice by pharmacologically blocking the TLR3 and MAPK pathway
Xiaobin Fang, Tianjiao Song, Ling Zheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117456-117456
Open Access | Times Cited: 3

Response to antifibrotic therapy and decrease of circulating BAG3 protein levels in systemic sclerosis patients with reduced forced vital capacity
Margot De Marco, Anna Basile, Anna Lisa Cammarota, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116578-116578
Open Access | Times Cited: 1

Mitophagy-Enhanced Nanoparticle-Engineered Mitochondria Restore Homeostasis of Mitochondrial Pool for Alleviating Pulmonary Fibrosis
Yi Wang, Li‐Fan Hu, Na-Hui Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 47, pp. 32705-32722
Closed Access | Times Cited: 1

Patient-centered care in pulmonary fibrosis: access, anticipate, and act
D. Hofman, Tonia Magrì, Catharina C. Moor, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access

Targeting angiogenic and proliferative mediators by montelukast & trimetazidine Ameliorates thioacetamide-induced liver fibrosis in rats
Rehab S. Abdelrahman, Ahmed A Elnfarawy, Asmaa E Nashy, et al.
Toxicology and Applied Pharmacology (2024), pp. 117208-117208
Closed Access

SQSTM1 upregulation-induced iron overload triggers endothelial ferroptosis in nicotine-exacerbated atherosclerosis
Xiaobin Fang, X.A. Zhuang, Ling Zheng, et al.
Life Sciences (2024) Vol. 361, pp. 123330-123330
Open Access

Page 1

Scroll to top